Literature DB >> 19648273

IFN regulatory factor 8 regulates MDM2 in germinal center B cells.

Jeff X Zhou1, Chang Hoon Lee, Chen Feng Qi, Hongsheng Wang, Zohreh Naghashfar, Sadia Abbasi, Herbert C Morse.   

Abstract

IFN regulatory factor 8 (IRF8) is a transcription factor that affects the differentiation and function of myeloid, dendritic, and B cells. Herein we report that IRF8 regulates the expression of Mdm2, a suppressor of p53-dependent and -independent apoptosis pathways, in germinal center (GC) B cells. In GC B cells of IRF8-deficient mice, Mdm2 transcripts were greatly down-regulated, and MDM2 protein was poorly expressed in GC of Irf8(-/-) mice. Small interfering RNA-induced repression of IRF8 in a GC-derived B cell line resulted in decreased expression of MDM2 at the protein level but increased expression of p53 and p21. We found that IRF8 binds to the Mdm2 P2 promoter, and that cotransfection of an IRF8 expression vector with an Mdm2 reporter construct stimulated significant increases in reporter activity. Additionally, transcripts of the p53 target Pmaip1 (Noxa) were significantly increased in IRF8-deficient GC B cells as well as in the IRF8 knockdown B cell line. Finally, cells deficient in IRF8 exhibited growth suppression and increased sensitivity to apoptosis induced by etoposide or IL-21. These results suggest that by regulating MDM2, IRF8 might allow GC B cells to tolerate physiological DNA breaks that otherwise would trigger apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648273      PMCID: PMC2759298          DOI: 10.4049/jimmunol.0803693

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

1.  BCL-6 regulates chemokine gene transcription in macrophages.

Authors:  L M Toney; G Cattoretti; J A Graf; T Merghoub; P P Pandolfi; R Dalla-Favera; B H Ye; A L Dent
Journal:  Nat Immunol       Date:  2000-09       Impact factor: 25.606

2.  Transcriptional analysis of the B cell germinal center reaction.

Authors:  Ulf Klein; Yuhai Tu; Gustavo A Stolovitzky; Jeffrey L Keller; Joseph Haddad; Vladan Miljkovic; Giorgio Cattoretti; Andrea Califano; Riccardo Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

3.  IL-21 induces the apoptosis of resting and activated primary B cells.

Authors:  Devangi S Mehta; Andrea L Wurster; Matthew J Whitters; Deborah A Young; Mary Collins; Michael J Grusby
Journal:  J Immunol       Date:  2003-04-15       Impact factor: 5.422

4.  Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma.

Authors:  Laura Pasqualucci; Anna Migliazza; Katia Basso; Jane Houldsworth; R S K Chaganti; Riccardo Dalla-Favera
Journal:  Blood       Date:  2002-12-19       Impact factor: 22.113

Review 5.  ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.

Authors:  Tomohiko Tamura; Keiko Ozato
Journal:  J Interferon Cytokine Res       Date:  2002-01       Impact factor: 2.607

6.  The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.

Authors:  Beverly W Baron; John Anastasi; Michael J Thirman; Yoichi Furukawa; Scott Fears; David C Kim; Federico Simone; Mark Birkenbach; Anthony Montag; Annamma Sadhu; Nancy Zeleznik-Le; Timothy W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

7.  A critical role for IL-21 in regulating immunoglobulin production.

Authors:  Katsutoshi Ozaki; Rosanne Spolski; Carl G Feng; Chen-Feng Qi; Jun Cheng; Alan Sher; Herbert C Morse; Chengyu Liu; Pamela L Schwartzberg; Warren J Leonard
Journal:  Science       Date:  2002-11-22       Impact factor: 47.728

8.  MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53.

Authors:  Zhuo Zhang; Hui Wang; Mao Li; Sudhir Agrawal; Xinbin Chen; Ruiwen Zhang
Journal:  J Biol Chem       Date:  2004-02-03       Impact factor: 5.157

9.  MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation.

Authors:  Yetao Jin; Hunjoo Lee; Shelya X Zeng; Mu-Shui Dai; Hua Lu
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

10.  IRF8 regulates B-cell lineage specification, commitment, and differentiation.

Authors:  Hongsheng Wang; Chang Hoon Lee; Chenfeng Qi; Prafullakumar Tailor; Jianxun Feng; Sadia Abbasi; Toru Atsumi; Herbert C Morse
Journal:  Blood       Date:  2008-09-17       Impact factor: 22.113

View more
  22 in total

1.  A reporter mouse reveals lineage-specific and heterogeneous expression of IRF8 during lymphoid and myeloid cell differentiation.

Authors:  Hongsheng Wang; Ming Yan; Jiafang Sun; Shweta Jain; Ryusuke Yoshimi; Sanaz Momben Abolfath; Keiko Ozato; William G Coleman; Ashley P Ng; Donald Metcalf; Ladina DiRago; Stephen L Nutt; Herbert C Morse
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

Review 2.  The regulation of MDM2 oncogene and its impact on human cancers.

Authors:  Yuhan Zhao; Haiyang Yu; Wenwei Hu
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-01-03       Impact factor: 3.848

3.  IFN regulatory factor 8 restricts the size of the marginal zone and follicular B cell pools.

Authors:  Jianxun Feng; Hongsheng Wang; Dong-Mi Shin; Marek Masiuk; Chen-Feng Qi; Herbert C Morse
Journal:  J Immunol       Date:  2010-12-22       Impact factor: 5.422

4.  Msh6 protects mature B cells from lymphoma by preserving genomic stability.

Authors:  Jonathan U Peled; Rani S Sellers; Maria D Iglesias-Ussel; Dong-Mi Shin; Cristina Montagna; Chunfang Zhao; Ziqiang Li; Winfried Edelmann; Herbert C Morse; Matthew D Scharff
Journal:  Am J Pathol       Date:  2010-10-07       Impact factor: 4.307

5.  Hyperprogressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate.

Authors:  Shumei Kato; Aaron Goodman; Vighnesh Walavalkar; Donald A Barkauskas; Andrew Sharabi; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2017-03-28       Impact factor: 12.531

6.  Apurinic/apyrimidinic endonuclease 2 regulates the expansion of germinal centers by protecting against activation-induced cytidine deaminase-independent DNA damage in B cells.

Authors:  Jeroen E J Guikema; Erin K Linehan; Nada Esa; Daisuke Tsuchimoto; Yusaku Nakabeppu; Robert T Woodland; Carol E Schrader
Journal:  J Immunol       Date:  2014-06-16       Impact factor: 5.422

7.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to November 2009.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-12-17       Impact factor: 0.196

Review 8.  MDM2, MDMX and p53 in oncogenesis and cancer therapy.

Authors:  Mark Wade; Yao-Cheng Li; Geoffrey M Wahl
Journal:  Nat Rev Cancer       Date:  2013-01-10       Impact factor: 60.716

9.  Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes.

Authors:  Susan L Slager; Sara J Achenbach; Yan W Asmann; Nicola J Camp; Kari G Rabe; Lynn R Goldin; Timothy G Call; Tait D Shanafelt; Neil E Kay; Julie M Cunningham; Alice H Wang; J Brice Weinberg; Aaron D Norman; Brian K Link; Jose F Leis; Celine M Vachon; Mark C Lanasa; Neil E Caporaso; Anne J Novak; James R Cerhan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-01-10       Impact factor: 4.254

10.  Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinoma.

Authors:  Lingeng Lu; Stephen G Gaffney; Vincent L Cannataro; Jeffrey Townsend
Journal:  Oral Oncol       Date:  2019-12-27       Impact factor: 5.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.